Back to top

MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases

MiNK Therapeutics (INKT) announced the appointment of Terese Hammond, MD as Head of Inflammatory and Pulmonary Diseases, effective immediately. In ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

MiNK Therapeutics, Inc. (INKT)